litlas
Log inCreate account

Gert Van Assche

Active 2001–2022

160
Papers
53,301
Citations
111
h-index
160
i10-index

Citations

Citations per year for Gert Van Assche1993: 1 citations1994: 2 citations2002: 3 citations2003: 28 citations2004: 71 citations2005: 118 citations2006: 161 citations2007: 176 citations2008: 197 citations2009: 277 citations2010: 357 citations2011: 384 citations2012: 399 citations2013: 551 citations2014: 623 citations2015: 585 citations2016: 598 citations2017: 664 citations2018: 642 citations2019: 2,265 citations2020: 2,307 citations2021: 1,852 citations2022: 1,376 citations2023: 1,115 citations2024: 1,558 citations2025: 591 citations2026: 11 citations1995–2001: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,235 citing papers, 18.8% of this breakdownUnited Kingdom: 1,311 citing papers, 7.6% of this breakdownChina: 1,227 citing papers, 7.1% of this breakdownItaly: 1,179 citing papers, 6.9% of this breakdownCanada: 1,063 citing papers, 6.2% of this breakdownFrance: 937 citing papers, 5.4% of this breakdownGermany: 851 citing papers, 4.9% of this breakdownNetherlands: 741 citing papers, 4.3% of this breakdownBelgium: 657 citing papers, 3.8% of this breakdownSpain: 627 citing papers, 3.6% of this breakdownJapan: 488 citing papers, 2.8% of this breakdownAustralia: 404 citing papers, 2.4% of this breakdown
0%18.8%Other 26.2%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology58.9%
  • Medicine29.9%
  • Immunology and Microbiology6.3%
  • Neuroscience1.6%
  • Agricultural and Biological Sciences1%
  • Nursing0.5%
  • Other1.8%

Topics

  • Inflammatory Bowel Disease21.3%
  • Microscopic Colitis7.4%
  • Gut microbiota and health4%
  • Rheumatoid Arthritis Research and Therapies3.6%
  • Autoimmune and Inflammatory Disorders3.2%
  • Biosimilars and Bioanalytical Methods2.7%
  • Other57.8%

Coauthors

All papers

Open in search
  1. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

    Authors: Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands, Stephen B. Hanauer, Jean‐Frédéric Colombel, William J. Sandborn, Gert Van Assche, Jeffrey Axler, Hyo Jong Kim, Silvio Danese, Irving H. Fox, Catherine Milch, Serap Sankoh, Tim Wyant, Jing Xu, Asit Parikh - New England Journal of Medicine 2013 cited by 2,852

  2. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

    Authors: Bruce E. Sands, William J. Sandborn, Remo Panaccione, Christopher D. O’Brien, Hongyan Zhang, Jewel Johanns, Omoniyi J. Adedokun, Katherine Li, Laurent Peyrin‐Biroulet, Gert Van Assche, Silvio Danese, Stephan R. Targan, María T. Abreu, Tadakazu Hisamatsu, Philippe Szapary, Colleen Marano - New England Journal of Medicine 2019 cited by 1,180

  3. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD

    Authors: Marco Daperno, Geert D’Haens, Gert Van Assche, Filip Baert, P. Bulois, V. Maunoury, R. Sostegni, Rodolfo Rocca, A. Pera, Annemie Gevers, Jean-Yves Mary, Jean-Frédéric Colombel, Paul Rutgeerts - Gastrointestinal Endoscopy 2004 cited by 1,774

  4. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

    Authors: Laurent Peyrin‐Biroulet, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Willem A. Bemelman, Robert V. Bryant, Geert D’Haens, Iris Dotan, Marla C. Dubinsky, Brian G. Feagan, Gionata Fiorino, Richard B. Gearry, Suneeta Krishnareddy, Péter L. Lakatos, Edward V. Loftus, Philippe Marteau, Pia Munkholm, Travis B. Murdoch, Íngrid Ordás, Remo Panaccione, Robert H. Riddell, Joannie Ruel, David T. Rubin, Mark Samaan, Corey A. Siegel, Mark S. Silverberg, Jaap Stoker, S Schreiber, Simon Travis, Gert Van Assche, Silvio Danese, Julián Panés, Guillaume Bouguen, Sarah O’Donnell, Benjamin Pariente, Shawn Winer, Stephen B. Hanauer, J -F Colombel - The American Journal of Gastroenterology 2015 cited by 1,838

  5. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

    Authors: Fernando Gomollón, Axel Dignaß, Vito Annese, Herbert Tilg, Gert Van Assche, James O. Lindsay, Laurent Peyrin‐Biroulet, Garret Cullen, Marco Daperno, Torsten Kucharzik, Florian Rieder, Sven Almér, Alessandro Armuzzi, Marcus Harbord, Jost Langhorst, Miquel Sans, Yehuda Chowers, Gionata Fiorino, Pascal Juillerat, Gerassimos J. Mantzaris, Fernando Rizzello, Stephan R. Vavricka, Paolo Gionchetti, on behalf of ECCO - Journal of Crohn s and Colitis 2016 cited by 2,071

  6. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

    Authors: Julián Panés, Damián García‐Olmo, Gert Van Assche, Jean‐Frédéric Colombel, Walter Reinisch, Daniel C. Baumgart, Axel Dignaß, Maria Nachury, Marc Ferrante, Lili Kazemi-Shirazi, Jean Charles Grimaud, Fernando de la Portilla, Eran Goldin, M Richard, Anne Leselbaum, Silvio Danese - The Lancet 2016 cited by 1,064

  7. Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease

    Authors: William J. Sandborn, Brian G. Feagan, Edward V. Loftus, Laurent Peyrin‐Biroulet, Gert Van Assche, Geert D’Haens, Stefan Schreiber, Jean‐Frédéric Colombel, James D. Lewis, Subrata Ghosh, Alessandro Armuzzi, Ellen Scherl, Hans Herfarth, L.M. Vitale, Mohamed‐Eslam F. Mohamed, Ahmed A. Othman, Qian Zhou, Bidan Huang, Roopal Thakkar, Aileen L. Pangan, Ana P. Lacerda, Julián Panés - Gastroenterology 2020 cited by 317

  8. Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

    Authors: William J. Sandborn, Gert Van Assche, Walter Reinisch, Jean‐Frédéric Colombel, Geert D’Haens, Douglas C. Wolf, Martina Kron, Mary Beth Tighe, Andreas Lazar, Roopal Thakkar - Gastroenterology 2011 cited by 1,258

  9. Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease

    Authors: Julián Panés, Damián García‐Olmo, Gert Van Assche, Jean‐Frédéric Colombel, Walter Reinisch, Daniel C. Baumgart, Axel Dignaß, Maria Nachury, Marc Ferrante, Lili Kazemi-Shirazi, Jean Charles Grimaud, Fernando de la Portilla, Eran Goldin, M Richard, Mary Carmen Díez, Ignacio Tagarro, Anne Leselbaum, Anne Leselbaum, Silvio Danese, Daniel C. Baumgart, Jean‐Frédéric Colombel, Daniel C. Baumgart, Gert Van Assche, Walter Reinisch, Damián García‐Olmo, Anton Stift, Jörg Tschmelitsch, Karl Mrak, Herbert Tilg, Irmgard Kroberger, André D’Hoore, Danny De Looze, Filip Baert, Paul Pattyn, Philippe Zerbib, Frank Zerbib, S Viennot, Jean‐Louis Dupas, P Orsoni, Xavier Hébuterne, Amine Rahili, Matthieu Allez, Yves Panís, Max Reinshagen, Roland Scherer, Andreas Sturm, Wolfgang Kruis, Daniel-Simon Duek, Matti Waterman, Adi Lahat-Zok, Oded Zmora, Hagit Tulchinsky, Yair Edden, Antonino Spinelli, Vito Annese, Imerio Angriman, Gabriele Riegler, Francesco Selvaggi, Bas Oldenburg, Lennard P. L. Gilissen, G Montfort, Mark Löwenberg, Adrianus Willem Bemelman, Raúl Almenara, María Dolores Martín‐Arranz, Mariano García‐Arranz, Javier P. Gisbert, Rosana Palasí, Javier Pérez Gisbert, José Manuel Herrera Justiniano, Ricardo Rada, Ma Teresa Butrón, Ricardo Rada, Antonio López–Sanromán, Joaquín Hinojosa de Val, Amparo Solana, Xavier González-Argenté, C. Martínez Pastor, Héctor Guadalajara, C. Martínez Pastor, Héctor Guadalajara - Gastroenterology 2017 cited by 485

  10. An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease

    Authors: Florian Rieder, Dominik Bettenworth, Christopher Ma, Claire E. Parker, Leeann Williamson, Sigrid Nelson, Gert Van Assche, Antonio Di Sabatino, Yoram Bouhnik, Ryan W. Stidham, Axel Dignaß, Gerhard Rogler, Stuart A. Taylor, Jaap Stoker, Jordi Rimola, Mark E. Baker, Joel G. Fletcher, Julián Panés, William J. Sandborn, Brian G. Feagan, Vipul Jairath - Alimentary Pharmacology & Therapeutics 2018 cited by 258

  11. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD

    Authors: João Sabino, Sara Vieira‐Silva, Kathleen Machiels, Marie Joossens, Gwen Falony, Vera Ballet, Marc Ferrante, Gert Van Assche, Van der Merwe, Séverine Vermeire, Jeroen Raes - Gut 2016 cited by 413

  12. Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease

    Authors: Maaike Vancamelbeke, Tim Vanuytsel, Ricard Farré, Sare Verstockt, Marc Ferrante, Gert Van Assche, Paul Rutgeerts, Frans Schuit, Séverine Vermeire, Ingrid Arijs, Isabelle Cleynen - Inflammatory Bowel Diseases 2017 cited by 265

  13. Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines

    Authors: Julián Panés, Yoram Bouhnik, Walter Reinisch, Jaap Stoker, Stuart A. Taylor, Daniel C. Baumgart, Silvio Danese, Steve Halligan, Borut Marinček, Celso Matos, Laurent Peyrin‐Biroulet, Jordi Rimola, Gerhard Rogler, Gert Van Assche, Sandro Ardizzone, Ahmed Ba‐Ssalamah, Maria Antonietta Bali, Davide Bellini, Livia Biancone, Fabiana Castiglione, Robert Ehehalt, Roberto Grassi, Torsten Kucharzik, Francesca Maccioni, Giovanni Maconi, Fernando Magro, J. Martín-Comín, Giovanni Morana, Douglas Pendsé, Shaji Sebastian, Alberto Signore, Damian Tolan, Jeroen A. W. Tielbeek, Dominik Weishaupt, Bart M. Wiarda, Andrea Laghi - Journal of Crohn s and Colitis 2013 cited by 663

  14. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

    Authors: David Laharie, Arnaud Bourreille, Julien Branche, Matthieu Allez, Yoram Bouhnik, Jérôme Filippi, Frank Zerbib, Guillaume Savoye, Maria Nachury, Jacques Moreau, Jean‐Charles Delchier, Jacques Cosnes, Elena Ricart, Olivier Dewit, Antonio López–Sanromán, Jean‐Louis Dupas, Franck Carbonnel, Gilles Bommelaer, Benoît Coffin, Xavier Roblin, Gert Van Assche, María Esteve, Martti Färkkilâ, Javier P. Gisbert, Philippe Marteau, Stéphane Nahon, Martine De Vos, Denis Franchimont, Jean-Yves Mary, Jean–Frédéric Colombel, Marc Lémann - The Lancet 2012 cited by 642

  15. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

    Authors: Axel Dignaß, James O. Lindsay, Andreas Sturm, Alastair Windsor, Jean–Frédéric Colombel, Mathieu Allez, Gert D'Haens, André D’Hoore, Gerassimos J. Mantzaris, Gottfried Novacek, Tom Öresland, Walter Reinisch, Miquel Sans, Eduard F. Stange, Séverine Vermeire, Simon Travis, Gert Van Assche - Journal of Crohn s and Colitis 2012 cited by 1,550

  16. Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

    Authors: Filip Baert, Maja Noman, Séverine Vermeire, Gert Van Assche, Geert D' Haens, An Carbonez, Paul Rutgeerts - New England Journal of Medicine 2003 cited by 2,018

  17. Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease

    Authors: Niels Vande Casteele, Marc Ferrante, Gert Van Assche, Vera Ballet, Griet Compernolle, Kristel Van Steen, Steven Simoens, Paul Rutgeerts, Ann Gils, Séverine Vermeire - Gastroenterology 2015 cited by 873

  18. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

    Authors: Geert D’Haens, Marc Ferrante, Séverine Vermeire, Filip Baert, Maja Noman, Liesbeth Moortgat, Patricia Geens, Doreen Iwens, Isolde Aerden, Gert Van Assche, Gust Van Olmen, Paul Rutgeerts - Inflammatory Bowel Diseases 2012 cited by 811

  19. Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment

    Authors: Ingrid Arijs, Gert De Hertogh, Katleen Lemaire, Roel Quintens, Leentje Van Lommel, Kristel Van Steen, Peter Leemans, Isabelle Cleynen, Gert Van Assche, Séverine Vermeire, Karel Geboes, Frans Schuit, Paul Rutgeerts - PLoS ONE 2009 cited by 305

  20. Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease

    Authors: Séverine Vermeire, Marie Joossens, Kristin Verbeke, Jun Wang, Kathleen Machiels, João Sabino, Marc Ferrante, Gert Van Assche, Paul Rutgeerts, Jeroen Raes - Journal of Crohn s and Colitis 2015 cited by 319

  21. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

    Authors: Geert D’Haens, Filip Baert, Gert Van Assche, Philip Caenepeel, Philippe Vergauwe, Hans A.R.E. Tuynman, Martine De Vos, Sander van Deventer, Larry Stitt, Allan Donner, Séverine Vermeire, Frank J. Van de Mierop, Jean-Charles Coche, J van der Woude, Thomas Ochsenkühn, Ad A. van Bodegraven, Philippe Van Hootegem, Guy Lambrecht, Fazia Mana, Paul Rutgeerts, Brian G. Feagan, Daniël W. Hommes - The Lancet 2008 cited by 1,238

  22. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

    Authors: Axel Dignaß, Rami Eliakim, Fernando Magro, Christian Maaser, Yehuda Chowers, Karel Geboes, Gerassimos J. Mantzaris, Walter Reinisch, Jean–Frédéric Colombel, Séverine Vermeire, Simon Travis, James O. Lindsay, Gert Van Assche - Journal of Crohn s and Colitis 2012 cited by 889

  23. Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update

    Authors: Emanuel Burri, Michel H. Maillard, Alain Schoepfer, Frank Seibold, Gert Van Assche, Pauline Rivière, David Laharie, Michael Manz, on behalf of the Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology - Digestion 2020 cited by 141

  24. Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial

    Authors: Paul Rutgeerts, Gert Van Assche, William J. Sandborn, Douglas C. Wolf, Karel Geboes, Jean–Frédéric Colombel, Walter Reinisch, Ashish Kumar, Andreas Lazar, Anne Camez, Kathleen G. Lomax, Paul F. Pollack, Geert D’Haens - Gastroenterology 2012 cited by 581